ID
17193
Description
A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia; ODM derived from: https://clinicaltrials.gov/show/NCT00210548
Link
https://clinicaltrials.gov/show/NCT00210548
Keywords
Versions (1)
- 8/30/16 8/30/16 -
Uploaded on
August 30, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Schizophrenia NCT00210548
Eligibility Schizophrenia NCT00210548
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
other dsm-iv axis i diagnosis
Data type
boolean
Alias
- UMLS CUI [1]
- C0270287
Description
decrease in total panss score
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0451383
- UMLS CUI [1,2]
- C0547047
Description
substance dependence
Data type
boolean
Alias
- UMLS CUI [1]
- C0038586
Description
failure to respond to different antipsychotic medications
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0438286
- UMLS CUI [1,2]
- C0040615
Description
pregnant, breast-feeding, planning to become pregnant
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
- UMLS CUI [3]
- C2081645
Similar models
Eligibility Schizophrenia NCT00210548
- StudyEvent: Eligibility
C0547047 (UMLS CUI [1,2])
C0040615 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])
C2081645 (UMLS CUI [3])